Natco Pharma Q2 net up 27 pc at Rs 84 crores
New Delhi: Natco Pharma today reported a 27.49 percent rise in consolidated net profit to Rs 84.4 crore for the second quarter ended September 30, 2017.
The company had posted a net profit of Rs 66.2 crore for the corresponding period of the previous fiscal, Natco Pharma said in a filing to BSE.
Consolidated total revenue of the company stood at Rs 432.2 crore for the quarter under review. It was Rs 471.1 crore for the same period a year ago.
Shares of Natco Pharma today settled at Rs 996.70 per scrip, up 2.28 percent on BSE.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd